By activating the GLP-1 and GIP receptors, it helps regulate insulin secretion and promotes a feeling of satiety in biological models
You typically don't need a prior diagnosis or referral the program's licensed clinician will evaluate you during the intake process
The Role of Lifestyle Integration While tirzepatide is highly effective, it is not a standalone solution
Tirzepatide Pathway (Dual Agonist): Gut Mimics GLP-1 + GIP Delays Gastric Emptying + Improves Insulin Sensitivity Result: Reduced Appetite + Balanced Blood Sugar Steady Weight Loss Retatrutide Pathway (Triple Agonist): Gut Mimics GLP-1 + GIP + Glucagon Delays Gastric Emptying + Improves Insulin Sensitivity + Stimulates Liver Result: Reduced Appetite + Increased Lipolysis (Fat Burning) + High Energy Expenditure Aggressive Weight Loss Why Retatrutide Might Be "Better" Experimental findings show that Retatrutide addresses the primary limitation of all previous weight loss peptides: adaptive thermogenesis
They found that at the highest dosage of 4.8 mg survodutide weekly, study participants lost 14.9% of their body weight in comparison with a placebo group (2.8% weight loss) [122]
Designed as a triple agonist, Retatrutide targets GLP-1, GIP, and glucagon receptorseach playing a pivotal role in weight management, energy regulation, and glucose metabolism
